This collection will give you access to select recordings of the 2017 Annual Meeting presentations and some of the associated pdf slides (see the topics tab for a complete list of the talks) .

If you would like continuing education credit, see the table below to purchase the collection + CME/CMLE or the collection + SAM.

The AMP 2017 Annual Meeting (November 16-18, 2017 in Salt Lake City, UT) showcased an impressive roster of speakers covering a wide range of topics in molecular diagnostics. The theme for the meeting was "Where Molecular Leads Medicine to Best Patient Care" and the presentations highlighted the true clinical utility of molecular diagnostics. In AMP 2017 Annual Meeting Highlights, catch up on the the most cutting-edge research in molecular pathology in topics ranging from CRISPR technologies, liquid biopsies, and the microbiome, to epigenetic roles in human disease, and new tools for interpreting the cancer genome. Click on the "Topics" tab for a list of the available presentations and click on the titles for more information about each session.

Duration:  13.25 hrs

If you have questions, please email AMPeducation@amp.org

If you wish to obtain CME/CMLE or SAMs, click on the appropriate link to purchase the collection +CME/CMLE or +SAM.

Note: Join the AMP Family to purchase this content for a deep discount!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

AMP is the leading organization in the field of molecular diagnostics, and the AMP Annual meeting is the premier gathering of molecular professionals. As technologies change and new challenges arise, members and non-members alike rely on the AMP meeting to obtain the critical information needed to ensure that their patients receive the best care and best results.

This collection contains downloadable PDF slides of many of the presentations given during the AMP 2017 Annual Meeting. See the "topics" tab for a list of all the presentations for which slides are available.

The digital files (PDFs) for the AMP 2017 Annual Meeting are:

• Free for all AMP members until February 15, 2018. After February 15, 2018 (11:59PM EST), the price increases to $99.00.
• Free for Non-members who registered for the meeting. They will be emailed a coupon code valid until February 15, 2018.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

How to Access the Presentation Slides

1. On the menu to the right, click on "add to basket"
2. Log in using your AMP credentials.
3. The system will automatically check your membership status and provide the correct price. Add coupon code if applicable.
4. Check out.
5. Click here for instructions on how to access the presentation slides.

Join the AMP Family for a discount on this item.

AMP hosted the Reference Materials forum to discuss genetic testing reference materials availability and needs (for test validation, quality control, and proficiency testing). Speakers presented a variety of current reference material development projects for molecular testing of inherited and acquired somatic genetic disorders followed by group discussion. 

This collection contains downloadable PDF slides of many of the presentations given during the Reference Material Forum Meeting which took place on November 14, 2017 in Salt Lake City, Utah. Click here for more details about the meeting.

The digital files (PDFs) for the Reference Material Forum Meeting are:

• Free for all AMP members.
• Free for Non-members who registered for the meeting. They will be emailed a coupon code valid until February 15, 2018.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

How to Access the Presentation Slides

1. On the menu to the right, click on "add to basket"
2. Log in using your AMP credentials.
3. The system will automatically check your membership status and provide the correct price. Add coupon code if applicable.
4. Check out.
5. To access the presentation slides, click on "My classroom" on the menu to the right.
6. Click on "AMP 2017 Reference Material Forum Meeting Presentations and Handouts.
7. Under "Resources", click on the PDF buttons to download the materials.

All sales are final. No refunds will be issued.

Free4members. Join the AMP Family for a discount on this item.

This product will give you access to the presentations (listed below) and pdf slides only.

If you would like continuing education credit for the course, see the table below to purchase the course + CME/CMLE or course + SAM.

Description:

Did you miss out on joining us in Charlotte for the AMP 2016 Annual Meeting? Were you there but missed something you really wanted to see? We have you covered with the AMP 2016 Annual Meeting Highlights. Select presentations were recorded and are now available for online viewing.

Presentations and Speakers :

The AMP Award for Excellence in Molecular Diagnostics Lecture: Discovering the Genetic Basis of Human Disease: The 35-Year Journey of Genomic Medicine (1.25)

• Eric Lander, PhD

It’s a Big Data World: Leveraging Available Genomic and Clinical Data to Advance Diagnostics

• Atul Butte, MD, PhD

• Christopher G. Chute, MD

A View from Across the Pond: European Models for Molecular Infectious Disease Testing

• Mark Wilcox, MD

• Kate Cuschieri, PhD

Liquid Biopsies and Analysis of Cell-Free DNA in Cancer Patients

• Michael R. Speicher, MD

• Maximillian Diehn, MD, PhD

CHIPping Away at the Mysteries of Hematopoeiesis: The Science and Clinical Implications of CHIP

• Benjamin Ebert, MD, PhD

• David P. Steensma, MD

Design, Validation, and Implementation of Effective Quality Control Materials for NGS/NIPS in a Clinical Laboratory

• Lisa V. Kalman, PhD

• Glenn E. Palomaki, PhD

Duration: 8.25 hrs

Note: Join the AMP Family to purchase this content for a deep discount!

The AMP 2016 Annual Meeting (November 10-12, 2016, Charlotte, North Carolina) showcased research in the latest advances in molecular medicine with the goal of enabling the highest quality health care.

The purchase of this product provides you with downloadable PDF slides of many of the AMP 2016 Annual Meeting presentations. See the "topics" tab for a list of all the presentations with slides available.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

This collection will give you access to select recordings from the AMP 2017 Global Congress. If you would like continuing education credit for the webinar, see the table below to purchase the collection + CME/CMLE or collection + SAM.

The AMP 2017 Global Congress in Berlin was a multi-disciplinary scientific program showcasing molecular technology with clinical applications in oncology, genetics, and infectious diseases. AMP Education has assembled the “AMP 2017 Global Congress Highlights,” which includes a selection of some of the most highly rated presentations and asked the speakers to record their talks from the meeting. This selection of excellent presentations includes:

Duration: 2.75 hr

Level of Instruction: Basic

You can purchase individual talks or purchase all of the AMP 2017 Global Congress Highlights for a discount.

• To purchase the entire series, click the "Add to Cart" button located on the right.
• To purchase individual talks, click on the "Purchase Individual Topics" button on the right, and select the particular talk(s) that you would like to purchase.

If you would like continuing education credit, click on the links below.

If you have questions, please email AMPeducation@amp.org

Note: Join the AMP Family to purchase this content for a deep discount!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

The AMP 2017 Global Congress (April 3-5, 2017 in Berlin, Germany) highlighted a multi-disciplinary scientific program showcasing molecular technology with clinical applications in oncology, genetics, and infectious diseases. The emphasis was on modern, user-friendly laboratory analytics supported by informatics tools to facilitate interpretation of actionable genomic test results.

The purchase of this product provides you with downloadable PDF slides of many of the presentations given during the AMP 2017 Global Congress. See the "topics" tab for a list of all the presentations with slides available.

The digital files (PDFs) for the AMP Global Congress 2017 Meeting are available free to meeting registrants for a limited time (three months) after the conference.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical, except that AMP authorizes you to view, copy, download and print for your own purposes.

This course includes all the recordings from the 2017 Molecular Pathology Outreach Course (MPOC), course materials, and a post-course exam. CME/CMLE and/or SAM credit is also included with the course.

This course is designed for pathologists, residents, laboratory directors and technologists who have some prior exposure to molecular diagnostic testing. The course features introductory information about the state of the science as well as a series of case studies illustrating some of the most current principles and practices in the field of Molecular Pathology.

This course includes all of the recorded presentations, course materials, and case studies from the live AMP 2017 Molecular Pathology Outreach Course (MPOC) held on November 15, 2017. It also includes a SAMs exam available for anyone to take as well as CME/CMLE and/or SAMs credit. Learn at your own pace and rewatch lectures as many times as you'd like.

Presented by the AMP Training & Education Committee

Duration: 5.5 hr

Level of Instruction: Basic

Last day to purchase course and claim credit: November 30, 2019

Maximum CME/CMLE credit available: 4.5

Maximum SAM credit available: 4.5

Click here for instructions on how to purchase and access the course.

All sales are final. No refunds will be issued.

CME/CMLE credit and SAMs credit are available with the purchase of this course.

To earn CME/CMLE or SAMs credit, you must complete all of the modules, pass the post-course exam with a grade of 80% or higher, and complete the post-course survey within the valid credit period noted below. You may not submit SAMs and CME/CMLE credit for the same content.

CME/CMLE Credit

This activity was planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of American Society for Clinical Pathology (ASCP) and the Association for Molecular Pathology (AMP). The ASCP is accredited by the ACCME to provide continuing medical education for physicians.

The ASCP designates this live educational activity for a maximum of 4.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This continuing medical laboratory education activity is recognized by the ASCP for up to 4.5 hours of CMLE credit. ASCP CMLE credit hours are acceptable for the ASCP Board of Certification (BOC) Certification Maintenance Program (CMP). CMLE credit hours meet the continuing education requirements for the ASCP Board of Certification Credential Maintenance Program (CMP) and state relicensure requirements for laboratory personnel. Participants should claim only the credit commensurate with the extent of their participation in the activity. 

SAM Credit

This activity is approved by the American Board of Pathology. Physicians should only claim credit commensurate with the extent of their participation in the activity. Participants must successfully complete the online exam (answering at least 80% of the questions correctly).

Note: Join the AMP Family to purchase this content for a deep discount!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

The AMP Molecular Genetic Pathology (MGP) Review Course is an intense update and review of molecular diagnostics that is geared towards individuals preparing for the Molecular Genetic Pathology (MGP) Subspecialty Certification Exam or for those looking for a refresher or an introduction to molecular genetic pathology. Learn directly from recognized experts in molecular pathology, most of whom hold the MGP certification.

This online course includes all the recorded presentations, course materials, case studies, and tests from the live course held on June 1-4, 2017. Learn at your own pace and rewatch lectures as many times as you'd like.

Note - registrants who attended the face-to-face course do not need to register for the online course to access the online materials.

CME/CMLE credit and SAMs credit are both available with the purchase of this course.

CE Credit

AMA PRA Category 1 Credit(s)™

This activity was planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Society for Clinical Pathology (ASCP) and the Association for Molecular Pathology. ASCP is accredited by the ACCME to provide continuing medical education for physicians.

The ASCP designates this enduring educational activity for a maximum of 22.75 AMA PRA Category 1 Credit(s) TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

This continuing medical laboratory education activity is recognized by the American Society for Clinical Pathology for 22.75 hours of CMLE credit. ASCP CMLE credit hours are acceptable for the ASCP Board of Certification (BOC) Certification Maintenance Program (CMP).CMLE credit hours meet the continuing education requirements for the ASCP Board of Certification Credential Maintenance Program (CMP) and state relicensure requirements for laboratory personnel. Participants should claim only the credit commensurate with the extent of their participation in the activity. 

SAMs Credit

This course is approved by the American Board of Pathology for 18.75 SAM credits. Physicians should only claim credit commensurate with the extent of their participation in the activity. Participants must successfully complete the online exam (answering at least 80% of the questions correctly).

DISCLAIMER: AMP makes no guarantee or assurances that completion of its courses or participation in any educational activity will in any manner ensure a passing score on any certification examination or activity post-test, or achievement of certification status. The AMP Molecular Genetic Pathology review course is an educational program provided by the Association for Molecular Pathology, (AMP) and is not sponsored or endorsed by the American Board of Pathology (ABP) or the American Board of Medical Genetics (ABMG).

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

In oncology, there are a variety of potential clinical applications for a minimally invasive blood test for DNA released from tumor cells. Such applications include detecting early stage disease, tracking response to therapy, prompt identification of disease relapse or recurrence, and recognition of clonal evolution.  Numerous small-scale studies have demonstrated that quantitation of mutations in circulating tumor DNA (ctDNA) is feasible from the blood of cancer patients. The increased adoption of targeted cancer therapies underscores the need to augment invasive tissue biopsies with alternative detection methods that rapidly monitor treatment response. Although most studies have been proof of principle, ctDNA methods hold great promise in cancer diagnostics.

Speaker: Christina Lockwood, PhD, DABCC, FACB

Duration: 1.0 hr

Level of Instruction: Basic

All sales are final. No refunds will be issued.

Note: Members of AMP can access this webinar at no cost. Join the AMP Family!

This product will give you access to the webinar only. If you would like continuing education credit for the webinar, see the table below to purchase the webinar + CME/CMLE or webinar + SAM.

Description:

This webinar will review the most recent revision of the World Health Organization (WHO) classification of acute leukemia with a particular focus on acute myeloid leukemia. A summary of changes to the classification of lymphoblastic leukemia/lymphoma and acute leukemias of ambiguous lineage will also be summarized.

A collaborative educational event presented by Association for Molecular Pathology (AMP) and Society for Hematopathology (SH).

Speaker: Daniel A. Arber, MD

Host: Mark D. Ewalt, MD

Duration: 1 hr

Level of Instruction: Intermediate

Click on the links below to purchase continuing education credit.

You may also be interested in:

• WHO 2016 Updates: Nodal Peripheral T-cell Lymphomas
• WHO 2016 Updates: B-Lymphoid Neoplasms (and how practice is changing)

Note: Members of AMP can access this webinar at no cost. Join the AMP Family!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

This product will give you access to the webinar only. If you would like continuing education credit for the webinar, see the table below to purchase the webinar + CME/CMLE or webinar + SAM.

Description:

In this presentation, Dr. Hsi will review important changes in the recently published update to the 2016 WHO classification of B-cell neoplasms. Topics include monoclonal B-cell lymphocytosis, in situ follicular neoplasia, pediatric type follicular lymphoma, and provisional entities such as large B-cell lymphoma with IRF rearrangement and EBV+ mucocutaneous ulcer. The appropriate molecular characterization of diffuse large B-cell lymphomas and high grade B-cell lymphomas will also be discussed.

A collaborative educational event presented by Association for Molecular Pathology (AMP) and Society for Hematopathology (SH).

Speaker: Eric D. Hsi, MD

Host: Mark D. Ewalt, MD

Duration: 1 hr

Level of Instruction: Basic

Click on the links below to purchase continuing education credit.

You might also be interested in:

• AMP 2017 Annual Meeting Highlights: Molecular Genetics and Biomarkers of B-cell Leukemias and Lymphomas
• AMP 2016 Annual Meeting Highlights: CHIPping Away at the Mysteries of Hematopoiesis

Note: Members of AMP can access this webinar at no cost. Join the AMP Family!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

This product will give you access to the webinar only. If you would like continuing education credit for the webinar, see the table below to purchase the webinar + CME/CMLE or webinar + SAM.

In this webinar, Dr. Tracy George will discuss updates in the classification of myeloproliferative neoplasms, also including eosinophilic neoplasms with recurring mutations, and mastocytosis. This includes new criteria for accelerated phase (response-to-TKI criteria) in chronic myeloid leukemia, WHO 2016 criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis, as well as eosinophilic neoplasms with and without recurring mutations. Updates in the diagnosis of mastocytosis, now its own chapter again in the WHO 2016 classification, will also be explained.

A collaborative educational event presented by Association for Molecular Pathology (AMP) and Society for Hematopathology (SH).

Speaker: Tracy I. George, MD

Host: Mark D. Ewalt, MD

Duration: 1 hr

Level of Instruction: Basic

Click on the links below to purchase continuing education credit.

You might also be interested in:

• WHO 2016 Updates: B Lymphoid Neoplasms (and how practice is changing)
• WHO 2016 Updates: Nodal Peripheral T-cell Lymphomas
• WHO 2016 Updates: Acute Leukemias

Note: Members of AMP can access this webinar at no cost. Join the AMP Family!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentation

This product will give you access to the webinar only. If you would like continuing education credit for the webinar, see the table below to purchase the webinar + CME/CMLE or webinar + SAM.

Description:

Following a brief overview on the difficulties encountered in the definition of the epidemiology, classification, diagnosis, prognosis, and therapy of peripheral T/NK-cell lymphomas, nodal peripheral T-cell lymphomas (PTCLs) will be discussed in detail. These neoplasms account for more than 60% of tumours stemming from peripheral T-lymphocytes. In the Revised WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, they correspond to 4 entities: PTCL, not otherwise specified (NOS), PTCLs related to follicular helper T-lymphocytes (FTH), ALK+ anaplastic large cell lymphoma (ALCL), and ALK- ALCL. Tumour related to TFH cells represent a new category, including angioimmunoblastic T-cell lymphoma (AITL), follicular T-cell lymphoma and neoplasms lacking the morphologic characteristics of the previous two subtypes but also stemming from TFH-elements. The latter group was in the past included among PTCLs/NOS. ALK- ALCL was promoted from provisional to accepted entity because of emerging molecular evidences. In addition, the new provisional category of breast implant-associated ALCL was included. Most of the changes introduced in the Revised WHO Classification by comparison with the 2008 fourth edition are due to the extensive application of molecular techniques, including gene expression profiling and next generation sequencing. All the changes will be highlighted and discussed.

A collaborative educational event presented by Association for Molecular Pathology (AMP) and Society for Hematopathology (SH).

Speaker: Stefano A. Pileri, MD

Host: Jennifer Dunlap, MD

Duration: 1 hr

Level of Instruction: Intermediate

Click on the links below to purchase continuing education credit.

You may also be interested in:

• WHO 2016 Updates: B-Lymphoid Neoplasms (and how practice is changing)

Note: Members of AMP can access this webinar at no cost. Join the AMP Family!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

This product will give you access to the webinar only. If you would like continuing education credit for the webinar, see the table below to purchase the webinar + CME/CMLE or webinar + SAM.

Description:

This webinar reviews the updated diagnostic criteria of myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms according to the recently revised WHO Classification, with emphasis on significant changes from the prior (2008) WHO Classification. New and revised entities within this group of diseases will be presented and the appropriate testing required to correctly diagnose these neoplasms will be discussed.

Speaker: Robert P. Hasserjian, MD

Host: Jennifer Dunlap, MD

Duration: 1 hr

Level of Instruction: Basic

If you would like continuing education credit, click on the links below.

You may also be interested in:

• WHO 2016 Updates: B-Lymphoid Neoplasms (and how practice is changing)
• WHO 2016 Updates: Nodal Peripheral T-cell Lymphomas
• WHO 2016 Updates: Acute Leukemias
• WHO 2016 Updates: MPN

Note: Members of AMP can access this webinar at no cost. Join the AMP Family!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

This product will give you access to the webinar only. If you would like continuing education credit for the webinar, see the table below to purchase the webinar + CME/CMLE or webinar + SAM.

Description:

In January 2017, a working group comprised of representatives from the Association for Molecular Pathology (AMP), College of American Pathologists (CAP), American Society of Clinical Oncology (ASCO), and American College of Medical Genetics and Genomics (ACMG) published the guidelines for the interpretation and reporting of somatic variants. This subject matter expert panel comprised of investigators with expertise in molecular pathology, medical genetics, and clinical oncology, assessed the current status of NGS-based testing for cancer and established standardized classification, annotation, interpretation, and reporting conventions for sequence variants associated with cancer.

In this webinar, Dr. Marilyn M. Li summarizes the guideline and provides a number of examples illustrating how to implement the classification system.

Practice Guideline Available Here

Speaker: Marilyn M. Li, MD

Host: Antonia R. Sepulveda, MD, PhD

Duration: 1 hr

Level of Instruction: Basic

Click on the links below to purchase continuing education credit.

You may also be interested in:

• Somatic Variant Interpretation and Reporting - The Informatics Underpinning in the Light of Recent AMP Guidelines

Note: Members of AMP can access this webinar at no cost. Join the AMP Family!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

   This product will give you access to the webinar only. If you would like continuing education credit for the webinar, see the table below to purchase the webinar + CME/CMLE or webinar + SAM.

Speaker: Lawrence J. Jennings, MD, PhD	Moderator:  Antonia R. Sepulveda, MD, PhD

Description: Validation of NGS-based testing for oncology panels can be challenging given the many steps and wide range of targeted mutations. In this presentation, Dr. Jennings will discuss the recent AMP/CAP guideline recommendations for validation and review practical ways to provide documented evidence with the clinical NGS reports.

Practice Guideline Available Here

Duration: 1 hr

Level of Instruction: Basic

Click on the links below to purchase continuing education credit.

You may also be interested in:

• Somatic Variant Interpretation and Reporting - The Informatics Underpinning in the Light of Recent AMP Guidelines
• AMP/ASCO/CAP Standards and Guidelines of Somatic Variant Interpretation and Reporting

Note: Members of AMP can access this webinar at no cost. Join the AMP Family!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

Recent definitions for clinical utility of molecular tests focus on whether a test result will alter treatment. This definition neglects other uses of molecular testing to diagnose disease, manage symptoms, prognosticate or predict future disease. The fullest realization of precision medicine will require embracing all aspects of clinical utility. This three-part webinar series, supported by AMP, presents the discussions of AMP’s Framework for the Evidence Needed to Demonstrate Clinical Utility (FEND) working group, and its resulting publication, “The Spectrum of Clinical Utilities in Molecular Pathology Testing Procedures for Inherited Conditions and Cancer: A Report of the Association for Molecular Pathology” (Joseph L, et al. J Mol Diagn. 2016;18[5]:605–619).

Part 1 - An Overview of AMP’s Framework for the Evidence Needed to Demonstrate Clinical Utility

Speakers: Loren Joseph, MD; Elaine Lyon, PhD

Host: Roger Klein, MD, JD

Part 2 - AMP’s Framework for the Evidence Needed to Demonstrate Clinical Utility – Oncology Cases

Speakers: Pranil Chandra, DO, FCAP, FASP; Rajyasree Emmadi, MD, FCAP

Host: Loren Joseph, MD

Part 3: AMP’s Framework for the Evidence Needed to Demonstrate Clinical Utility – Inherited Conditions

Speakers: Stephanie Hallam, PhD, FACMG, MBA; Victoria Pratt, PhD, FACMG

Host: Elaine Lyon, PhD

Practice Guideline Available Here

Total Duration: 3 hr

All sales are final. No refunds will be issued.

Note: Members of AMP can access this webinar at no cost. Join the AMP Family!